Role of IL-27 in Epstein-Barr virus infection revealed by IL-27RA deficiency.
Journal
Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462
Informations de publication
Date de publication:
20 Mar 2024
20 Mar 2024
Historique:
received:
11
11
2022
accepted:
20
02
2024
medline:
21
3
2024
pubmed:
21
3
2024
entrez:
21
3
2024
Statut:
aheadofprint
Résumé
Epstein-Barr virus (EBV) infection can engender severe B cell lymphoproliferative diseases
Identifiants
pubmed: 38509369
doi: 10.1038/s41586-024-07213-6
pii: 10.1038/s41586-024-07213-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature Limited.
Références
Latour, S. & Fischer, A. Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: lessons from genetic diseases. Immunol. Rev. 291, 174–189 (2019).
pubmed: 31402499
doi: 10.1111/imr.12791
Taylor, G. S., Long, H. M., Brooks, J. M., Rickinson, A. B. & Hislop, A. D. The immunology of Epstein-Barr virus-induced disease. Annu. Rev. Immunol. 33, 787–821 (2015).
pubmed: 25706097
doi: 10.1146/annurev-immunol-032414-112326
Dunmire, S. K., Hogquist, K. A. & Balfour, H. H. Infectious mononucleosis. Curr. Top. Microbiol. Immunol. 390, 211–240 (2015).
pubmed: 26424648
pmcid: 4670567
Tangye, S. G. & Latour, S. Primary immunodeficiencies reveal the molecular requirements for effective host defense against EBV infection. Blood 135, 644–655 (2020).
pubmed: 31942615
doi: 10.1182/blood.2019000928
Hirahara, K. et al. Asymmetric action of STAT transcription factors drives transcriptional outputs and cytokine specificity. Immunity 42, 877–889 (2015).
pubmed: 25992861
doi: 10.1016/j.immuni.2015.04.014
Kastelein, R. A., Hunter, C. A. & Cua, D. J. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu. Rev. Immunol. 25, 221–242 (2007).
pubmed: 17291186
doi: 10.1146/annurev.immunol.22.012703.104758
Huang, Z. et al. IL-27 promotes the expansion of self-renewing CD8
pubmed: 31164392
pmcid: 6683984
doi: 10.1084/jem.20190173
Munz, C. Latency and lytic replication in Epstein-Barr virus-associated oncogenesis. Nat. Rev. Microbiol. 17, 691–700 (2019).
pubmed: 31477887
doi: 10.1038/s41579-019-0249-7
Shannon-Lowe, C. & Rickinson, A. The global landscape of EBV-associated tumors. Front. Oncol. 9, 713 (2019).
pubmed: 31448229
pmcid: 6691157
doi: 10.3389/fonc.2019.00713
Callan, M. F. et al. Direct visualization of antigen-specific CD8
pubmed: 9565632
pmcid: 2212279
doi: 10.1084/jem.187.9.1395
Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434–443 (2020).
pubmed: 32461654
pmcid: 7334197
doi: 10.1038/s41586-020-2308-7
Sprecher, C. A. et al. Cloning and characterization of a novel class I cytokine receptor. Biochem. Biophys. Res. Commun. 246, 82–90 (1998).
pubmed: 9600072
doi: 10.1006/bbrc.1998.8576
Pflanz, S. et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 172, 2225–2231 (2004).
pubmed: 14764690
doi: 10.4049/jimmunol.172.4.2225
Chen, Q. et al. Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 407, 916–920 (2000).
pubmed: 11057672
doi: 10.1038/35038103
Owaki, T. et al. A role for IL-27 in early regulation of Th1 differentiation. J. Immunol. 175, 2191–2200 (2005).
pubmed: 16081786
doi: 10.4049/jimmunol.175.4.2191
Yoshida, H. & Hunter, C. A. The immunobiology of interleukin-27. Annu. Rev. Immunol. 33, 417–443 (2015).
pubmed: 25861977
doi: 10.1146/annurev-immunol-032414-112134
Artis, D. et al. The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. J. Immunol. 173, 5626–5634 (2004).
pubmed: 15494513
doi: 10.4049/jimmunol.173.9.5626
Schneider, R., Yaneva, T., Beauseigle, D., El-Khoury, L. & Arbour, N. IL-27 increases the proliferation and effector functions of human naive CD8+ T lymphocytes and promotes their development into Tc1 cells. Eur. J. Immunol. 41, 47–59 (2011).
pubmed: 21182076
doi: 10.1002/eji.201040804
Charlot-Rabiega, P., Bardel, E., Dietrich, C., Kastelein, R. & Devergne, O. Signaling events involved in interleukin 27 (IL-27)-induced proliferation of human naive CD4
pubmed: 21669870
pmcid: 3149329
doi: 10.1074/jbc.M111.221010
Pflanz, S. et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4
pubmed: 12121660
doi: 10.1016/S1074-7613(02)00324-2
Pagano, G. et al. Interleukin-27 potentiates CD8
Harker, J. A. et al. Interleukin-27R signaling mediates early viral containment and impacts innate and adaptive immunity after chronic lymphocytic choriomeningitis virus infection. J. Virol. https://doi.org/10.1128/JVI.02196-17 (2018).
Pratumchai, I. et al. B cell-derived IL-27 promotes control of persistent LCMV infection. Proc. Natl Acad. Sci. USA https://doi.org/10.1073/pnas.2116741119 (2022).
Devergne, O., Birkenbach, M. & Kieff, E. Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc. Natl Acad. Sci. USA 94, 12041–12046 (1997).
pubmed: 9342359
pmcid: 23696
doi: 10.1073/pnas.94.22.12041
Devergne, O. et al. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J. Virol. 70, 1143–1153 (1996).
pubmed: 8551575
pmcid: 189923
doi: 10.1128/jvi.70.2.1143-1153.1996
Niedobitek, G., Pazolt, D., Teichmann, M. & Devergne, O. Frequent expression of the Epstein-Barr virus (EBV)-induced gene, EBI3, an IL-12 p40-related cytokine, in Hodgkin and Reed-Sternberg cells. J. Pathol. 198, 310–316 (2002).
pubmed: 12375263
doi: 10.1002/path.1217
Larousserie, F. et al. Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cells. Am. J. Pathol. 166, 1217–1228 (2005).
pubmed: 15793300
pmcid: 1602381
doi: 10.1016/S0002-9440(10)62340-1
Kang, M. S. & Kieff, E. Epstein-Barr virus latent genes. Exp. Mol. Med. 47, e131 (2015).
pubmed: 25613728
pmcid: 4314583
doi: 10.1038/emm.2014.84
Tosato, G. et al. Monocyte-derived human B-cell growth factor identified as interferon-β
pubmed: 2829354
Tosato, G., Tanner, J., Jones, K. D., Revel, M. & Pike, S. E. Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells. J. Virol. 64, 3033–3041 (1990).
pubmed: 2159561
pmcid: 249488
doi: 10.1128/jvi.64.6.3033-3041.1990
Chehboun, S. et al. Epstein-Barr virus-induced gene 3 (EBI3) can mediate IL-6 trans-signaling. J. Biol. Chem. 292, 6644–6656 (2017).
pubmed: 28280243
pmcid: 5399113
doi: 10.1074/jbc.M116.762021
Puel, A., Bastard, P., Bustamante, J. & Casanova, J. L. Human autoantibodies underlying infectious diseases. J. Exp. Med. https://doi.org/10.1084/jem.20211387 (2022).
Kisand, K. et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J. Exp. Med. 207, 299–308 (2010).
pubmed: 20123959
pmcid: 2822605
doi: 10.1084/jem.20091669
Puel, A. et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J. Exp. Med. 207, 291–297 (2010).
pubmed: 20123958
pmcid: 2822614
doi: 10.1084/jem.20091983
Nanki, T. et al. Suppression of elevations in serum C reactive protein levels by anti-IL-6 autoantibodies in two patients with severe bacterial infections. Ann. Rheum. Dis. 72, 1100–1102 (2013).
pubmed: 23349134
doi: 10.1136/annrheumdis-2012-202768
Puel, A. et al. Recurrent staphylococcal cellulitis and subcutaneous abscesses in a child with autoantibodies against IL-6. J. Immunol. 180, 647–654 (2008).
pubmed: 18097067
doi: 10.4049/jimmunol.180.1.647
Bastard, P. et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science https://doi.org/10.1126/science.abd4585 (2020).
Bastard, P. et al. Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine. J. Exp. Med. https://doi.org/10.1084/jem.20202486 (2021).
Zhang, Q. et al. Autoantibodies against type I IFNs in patients with critical influenza pneumonia. J. Exp. Med. https://doi.org/10.1084/jem.20220514 (2022).
Fournier, B. & Latour, S. Immunity to EBV as revealed by immunedeficiencies. Curr. Opin. Immunol. 72, 107–115 (2021).
pubmed: 33989894
doi: 10.1016/j.coi.2021.04.003
Kawamoto, K. et al. A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features. Haematologica 103, 1018–1028 (2018).
pubmed: 29242302
pmcid: 6058795
doi: 10.3324/haematol.2017.174177
Alosaimi, M. F. et al. Immunodeficiency and EBV-induced lymphoproliferation caused by 4-1BB deficiency. J. Allergy Clin. Immunol. 144, 574–583 (2019).
pubmed: 30872117
pmcid: 6688916
doi: 10.1016/j.jaci.2019.03.002
Rodriguez, R. et al. Concomitant PIK3CD and TNFRSF9 deficiencies cause chronic active Epstein-Barr virus infection of T cells. J. Exp. Med. 216, 2800–2818 (2019).
pubmed: 31537641
pmcid: 6888974
doi: 10.1084/jem.20190678
Somekh, I. et al. CD137 deficiency causes immune dysregulation with predisposition to lymphomagenesis. Blood 134, 1510–1516 (2019).
pubmed: 31501153
pmcid: 6839947
doi: 10.1182/blood.2019000644
Hoshino, Y., Nishikawa, K., Ito, Y., Kuzushima, K. & Kimura, H. Kinetics of Epstein-Barr virus load and virus-specific CD8+ T cells in acute infectious mononucleosis. J. Clin. Virol. 50, 244–246 (2011).
pubmed: 21185773
doi: 10.1016/j.jcv.2010.11.017
Martin, E. et al. CTP synthase 1 deficiency in humans reveals its central role in lymphocyte proliferation. Nature 510, 288–292 (2014).
pubmed: 24870241
pmcid: 6485470
doi: 10.1038/nature13386
Yamazaki, Y. et al. Two novel gain-of-function mutations of STAT1 responsible for chronic mucocutaneous candidiasis disease: impaired production of IL-17A and IL-22, and the presence of anti-IL-17F autoantibody. J. Immunol. 193, 4880–4887 (2014).
pubmed: 25288569
doi: 10.4049/jimmunol.1401467
Toubiana, J. et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood 127, 3154–3164 (2016).
pubmed: 27114460
pmcid: 4920021
doi: 10.1182/blood-2015-11-679902
Izawa, K. et al. Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection. J. Exp. Med. 214, 73–89 (2017).
pubmed: 28011863
pmcid: 5206497
doi: 10.1084/jem.20160784
Durandy, A., Kracker, S. & Fischer, A. Primary antibody deficiencies. Nat. Rev. Immunol. 13, 519–533 (2013).
pubmed: 23765059
doi: 10.1038/nri3466
Fournier, B. et al. Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection. J. Exp. Med. https://doi.org/10.1084/jem.20192262 (2020).
McStay, G. P., Salvesen, G. S. & Green, D. R. Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways. Cell Death Differ. 15, 322–331 (2008).
pubmed: 17975551
doi: 10.1038/sj.cdd.4402260
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
pubmed: 23104886
doi: 10.1093/bioinformatics/bts635
Anders, S., Pyl, P. T. & Huber, W. HTSeq—a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166–169 (2015).
pubmed: 25260700
doi: 10.1093/bioinformatics/btu638
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
pubmed: 25516281
pmcid: 4302049
doi: 10.1186/s13059-014-0550-8
Edgar, R., Domrachev, M. & Lash, A. E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207–210 (2002).
pubmed: 11752295
pmcid: 99122
doi: 10.1093/nar/30.1.207